App tracks Parkinson's symptoms against the menstrual cycle in women
Tests a phone app that tracks Parkinson's symptoms across the menstrual cycle in women.
Plain-language title generated from the registry record
Registry title: Enabling Women With Parkinson's Disease to Identify and Better Manage Hormonal Triggers of Parkinsonian Symptoms
Key facts
- Where
- Grenoble, Nantes, Rennes, and Toulouse, FranceSee the 4 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 56 years old?
Source: NCT06582212, who can take part
Where in France
- CHU Grenoble AlpesGrenoble, FranceTaking people
- CHU Nantes Hôpital LaennecNantes, FranceTaking people
- CHU Rennes -Site PontchaillouRennes, FranceTaking people
- CHU ToulouseToulouse, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital, Grenoble
- Trial code
- NCT06582212
- Record updated
- 2 October 2026
- Original description
Forty percent of people living worldwide with Parkinson's disease (PD) are women. Twenty percent of patients have PD onset under the age of 60 years, a time when women may encounter significant caregiving responsibilities along with occupational and other competing demands.Read full original descriptionShow less
Enabling Women With Parkinson's Disease to Identify and Better Manage Hormonal Triggers
Forty percent of people living worldwide with Parkinson's disease (PD) are women. Twenty percent of patients have PD onset under the age of 60 years, a time when women may encounter significant caregiving responsibilities along with occupational and other competing demands.
Studies with surveys of women with PD (WwPD) have reported worsening of PDrelated symptoms especially in the week prior and the week of menses. However, prospective evidence is scarce and clinical guidelines to manage this issue do not exist. As a result, care is either non-existent or fragmented.
The investigators propose a French multicentre prospective pilot study to capture changes in PD symptoms in relation to the stages of the menstrual cycle aiming at reducing hormonal related worsening in PD symptoms through neurologist intervention and/or patient selfmanagement.
Digital technology will remotely enable patient reported outcome (PRO) tracking through the My Moves Matter app changes in PD symptoms during several months. This information will then help neurologists to customize treatment.
Changes in motor symptoms will also be highlighted by tracking through the use of a wearable device (PDMonitor) to objectively detect motor changes together with the app.
This will further support the reliability of the app. This study will provide evidence for the impact of the menstrual cycle on PD and help neurologists and patients to better manage PD symptoms related to these hormonal changes.
Inclusion: Non-menopausal women; Diagnosis of PD according to the MDS criteria onset of PD symptoms since at least two years before inclusion; Age 18-56 years; On stable medication regimen for PD for at least two months without foreseen need to modify it within the next three months; With and without OCP or intrauterine devices (IUD.
Exclusion: Any condition that, in the opinion of the investigator, will preclude the participant from successfully or safely completing study procedures (i.e., dementia, severe depression, etc.); Post-menopausal women with PD; People not able to give an informed consent.